GPS1

G protein pathway suppressor 1, the group of COP9 signalosome

Basic information

Region (hg38): 17:82050690-82057470

Links

ENSG00000169727NCBI:2873OMIM:601934HGNC:4549Uniprot:Q13098AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the GPS1 gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the GPS1 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
1
clinvar
2
clinvar
3
missense
17
clinvar
1
clinvar
18
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
1
1
non coding
0
Total 0 0 17 2 2

Variants in GPS1

This is a list of pathogenic ClinVar variants found in the GPS1 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
17-82050705-T-C not specified Uncertain significance (Dec 03, 2021)2264007
17-82050728-C-T not specified Likely benign (Jan 03, 2024)3153382
17-82051552-C-G not specified Uncertain significance (Aug 16, 2022)2342657
17-82051565-G-A not specified Uncertain significance (Apr 12, 2022)2345671
17-82051566-G-A Benign (Dec 31, 2019)716492
17-82051589-C-T not specified Uncertain significance (Jun 17, 2024)3313871
17-82051600-C-T not specified Uncertain significance (Mar 24, 2023)2517688
17-82051601-G-A not specified Uncertain significance (Mar 30, 2024)3313869
17-82051612-G-A not specified Uncertain significance (May 20, 2024)3313870
17-82051761-G-A Likely benign (Oct 01, 2022)2648483
17-82052335-C-T not specified Uncertain significance (Mar 28, 2024)3282531
17-82052344-C-T not specified Uncertain significance (Aug 21, 2023)2619875
17-82052367-C-T not specified Uncertain significance (May 06, 2024)3282533
17-82052433-C-G not specified Uncertain significance (Apr 18, 2023)2537993
17-82053890-G-A not specified Uncertain significance (Jul 31, 2023)2614996
17-82053898-G-A not specified Uncertain significance (Mar 01, 2024)2210948
17-82053918-G-A Likely benign (Jul 01, 2022)2648484
17-82053947-C-T not specified Uncertain significance (Dec 08, 2023)3102045
17-82053994-A-G not specified Uncertain significance (Dec 09, 2023)3102046
17-82054010-T-C not specified Uncertain significance (Jun 17, 2024)2371450
17-82054033-C-G not specified Uncertain significance (Aug 28, 2023)2621847
17-82054042-G-A not specified Uncertain significance (Jul 12, 2023)2611218
17-82054546-C-A not specified Uncertain significance (Apr 04, 2023)2532647
17-82054573-G-A Benign (Sep 10, 2018)1244084
17-82054634-C-T Benign (Apr 03, 2018)709299

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
GPS1protein_codingprotein_codingENST00000392358 136780
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.9980.00181125374091253830.0000359
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense1.862353300.7120.00002113430
Missense in Polyphen4096.9960.41239954
Synonymous-3.301951451.350.00001011023
Loss of Function4.48227.30.07340.00000133311

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.000.00
Ashkenazi Jewish0.0001050.0000995
East Asian0.000.00
Finnish0.00004810.0000462
European (Non-Finnish)0.00004600.0000442
Middle Eastern0.000.00
South Asian0.00006540.0000653
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Essential component of the COP9 signalosome complex (CSN), a complex involved in various cellular and developmental processes. The CSN complex is an essential regulator of the ubiquitin (Ubl) conjugation pathway by mediating the deneddylation of the cullin subunits of SCF-type E3 ligase complexes, leading to decrease the Ubl ligase activity of SCF-type complexes such as SCF, CSA or DDB2. The complex is also involved in phosphorylation of p53/TP53, c-jun/JUN, IkappaBalpha/NFKBIA, ITPK1 and IRF8/ICSBP, possibly via its association with CK2 and PKD kinases. CSN- dependent phosphorylation of TP53 and JUN promotes and protects degradation by the Ubl system, respectively. Suppresses G- protein- and mitogen-activated protein kinase-mediated signal transduction. {ECO:0000269|PubMed:11285227, ECO:0000269|PubMed:11337588, ECO:0000269|PubMed:12628923, ECO:0000269|PubMed:12732143, ECO:0000269|PubMed:9535219}.;
Pathway
DNA Repair;Vesicle-mediated transport;Membrane Trafficking;Post-translational protein modification;Metabolism of proteins;Clathrin-mediated endocytosis;Neddylation;Cargo recognition for clathrin-mediated endocytosis;DNA Damage Recognition in GG-NER;Global Genome Nucleotide Excision Repair (GG-NER);Formation of TC-NER Pre-Incision Complex;Transcription-Coupled Nucleotide Excision Repair (TC-NER);Nucleotide Excision Repair (Consensus)

Recessive Scores

pRec
0.0897

Intolerance Scores

loftool
0.0511
rvis_EVS
-0.89
rvis_percentile_EVS
10.43

Haploinsufficiency Scores

pHI
0.245
hipred
Y
hipred_score
0.728
ghis
0.579

Essentials

essential_gene_CRISPR
E
essential_gene_CRISPR2
E
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.770

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Gps1
Phenotype
embryo phenotype; liver/biliary system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; homeostasis/metabolism phenotype; growth/size/body region phenotype;

Gene ontology

Biological process
inactivation of MAPK activity;protein deneddylation;nucleotide-excision repair, DNA damage recognition;transcription-coupled nucleotide-excision repair;JNK cascade;negative regulation of GTPase activity;post-translational protein modification
Cellular component
nucleoplasm;cytosol;COP9 signalosome
Molecular function
GTPase inhibitor activity;protein binding